Insight Molecular Diagnostics

Develops molecular diagnostic tests for transplant rejection and oncology.

Founded 2009 · 49 employees · United States · Public

Listed:

Nasdaq: IMDX

Subsidiaries:

Insight Molecular Labs, Insight Genetics